Lombardi, Carlo Mario
 Distribuzione geografica
Continente #
NA - Nord America 8.901
EU - Europa 4.678
AS - Asia 2.294
OC - Oceania 16
AF - Africa 14
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.919
Nazione #
US - Stati Uniti d'America 8.873
CN - Cina 1.389
UA - Ucraina 1.248
PL - Polonia 1.040
DE - Germania 619
IT - Italia 599
HK - Hong Kong 367
FI - Finlandia 361
SG - Singapore 252
IE - Irlanda 246
GB - Regno Unito 197
IN - India 174
FR - Francia 152
SE - Svezia 81
TR - Turchia 38
BE - Belgio 35
VN - Vietnam 35
CZ - Repubblica Ceca 34
CA - Canada 25
RU - Federazione Russa 21
NL - Olanda 18
AU - Australia 14
TH - Thailandia 7
EU - Europa 6
MU - Mauritius 6
BR - Brasile 5
ES - Italia 5
JP - Giappone 5
SA - Arabia Saudita 5
TN - Tunisia 5
IR - Iran 4
PH - Filippine 4
AL - Albania 3
AZ - Azerbaigian 3
CL - Cile 3
HU - Ungheria 3
SK - Slovacchia (Repubblica Slovacca) 3
HR - Croazia 2
ID - Indonesia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
RO - Romania 2
SI - Slovenia 2
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
HT - Haiti 1
IQ - Iraq 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
PR - Porto Rico 1
ZA - Sudafrica 1
Totale 15.919
Città #
Fairfield 1.244
Warsaw 1.039
Jacksonville 919
Woodbridge 792
Ashburn 742
Chandler 628
Houston 588
Seattle 524
Cambridge 520
Wilmington 500
Ann Arbor 481
Princeton 447
Hong Kong 366
Nanjing 312
Beijing 270
Dublin 245
Helsinki 244
New York 221
Singapore 155
Pune 107
Nanchang 100
Des Moines 96
Brescia 95
Shenyang 87
Dearborn 85
Changsha 84
San Diego 83
Hebei 78
Shanghai 70
Milan 59
Tianjin 59
Jiaxing 57
Jinan 55
London 36
Dong Ket 34
Kocaeli 34
Brussels 33
Los Angeles 33
Kunming 31
Brno 30
Lancaster 29
Hangzhou 28
Munich 28
Rome 27
Verona 27
Ningbo 25
Frankfurt am Main 23
San Francisco 21
Zhengzhou 21
Taizhou 20
Haikou 18
Orange 17
Washington 16
Guangzhou 15
Lanzhou 15
Boardman 13
Toronto 12
Lappeenranta 9
Kilburn 8
Canberra 7
Norwalk 7
Padova 7
Phoenix 7
Prevalle 7
Stockholm 7
Taiyuan 7
Acton 6
Florence 6
Hanover 6
Novara 6
Catania 5
Chicago 5
Leipzig 5
North York 5
Peccioli 5
Riyadh 5
Strasbourg 5
Augusta 4
Bangkok 4
Bologna 4
Calcinato 4
Changchun 4
Curno 4
Hefei 4
Naples 4
New Bedfont 4
Olomouc 4
Ottawa 4
Palermo 4
Redwood City 4
Reggio Nell'emilia 4
Rende 4
San Mateo 4
Tokyo 4
Tunis 4
Venice 4
Borgaro Torinese 3
Bratislava 3
Brindisi 3
Calolziocorte 3
Totale 12.151
Nome #
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 268
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 241
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 226
Can we improve the treatment of congestion in heart failure? 212
May 2020 at a glance: ischaemic heart failure and sex-related differences 210
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 209
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 206
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 201
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 186
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 154
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 145
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 142
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 140
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 140
Amino acids and derivatives, a new treatment of chronic heart failure? 135
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 133
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 130
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 126
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 117
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 115
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 115
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 112
Neurohormonal activation in acute heart failure: results from VERITAS 111
N-3 PUFA increase bioavailability and function of endothelial progenitor cells 110
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 109
The management of acute heart failure. 108
Can we prevent or treat renal dysfunction in acute heart failure? 105
N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure 104
Prognostic value of the absolute lymphocyte count in patients admitted for acute heart failure 103
Anemia and heart failure : a cause of progression or only a consequence? 102
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 102
Heart failure and anemia: Effects on prognostic variables 101
The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy 101
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 101
Serelaxin a novel treatment for acute heart failure 100
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 97
Echocardiographic elastic properties of ascending aorta and their relationship with exercise capacity in patients with non-ischemic dilated cardiomyopathy 97
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 97
A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure 97
Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health 96
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 96
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. 94
The need for evaluating right ventricular adaptation and ventriculo–arterial coupling 94
Six-year prognosis of diabetic patients with coronary artery disease. 93
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 93
Novel insight into the dangerous connection between diabetes and heart failure 93
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 93
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 91
Nutritional Deficiency in Patients with Heart Failure. 91
Assessment of Congestion in Acute Heart Failure: When Simplicity Does Not Go Along With Accuracy 91
Exercise performance is a prognostic indicator in elderly patients with chronic heart failure: Application of metabolic exercise cardiac kidney indexes score 90
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 90
Red cell distribution width and chronic heart failure: prognostic role beyond echocardiographic parameters. 89
Role of fluid retention in patients hospitalised for acute heart failure. 88
Prediction of 1-year outcomes after an acute heart failure hospitalisation: importance of variables measured at the time of discharge. 88
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 87
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. 85
Is there a role for ivabradine beyond its conventional use? 84
Cardiorenal Interactions 84
Iron deficiency in heart failure 83
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 83
Updates in heart failure: what last year brought to us 83
Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure 82
Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome 82
Mode of death and hospitalization from the second follow-up serial infusions of nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes 82
Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis 82
In-hospital worsening heart failure in patients admitted for acute heart failure 82
Dobutamine stress echocardiography in pulmonary arterial hypertension 82
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure 81
Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? 81
Preoperative cardiac risks in noncardiac surgery: The role of coronary angiography 81
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: early in vivo cardiovascular effects 81
Long-term prognostic value of peak VO2 in patients with heart failure on chronic beta-blocker therapy. 80
Apnee notturne e insufficienza cardiaca: un problema in via di soluzione. 80
Prognostic Evaluation Of The Ascending Aorta's Elastic Properties In Patients With Non-Ischemic Dilated Cardiomyopathy: An Echocardiographic Long-Term Follow-Up Study. 80
Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation 80
Early readmission for heart failure: An avoidable or ineluctable debacle? 79
January 2020 at a glance: translational medicine, predictors of outcome and treatments 78
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 77
Successful switch to sitaxsentan in a patient with HIV-related pulmonary arterial hypertension and late intolerance to nonselective endothelin receptor blockade 77
The Additional Role Of Diabetes Mellitus On Hypertension-Related Aortic Stiffness. 77
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 77
September 2019 at a glance: focus on devices 76
Le pressioni di riempimento ventricolari e la risposta ventilatoria allo sforzo identificano i pazienti con insufficienza cardiaca ad alto rischio di eventi nonostante la terapia beta-bloccante. 75
Acute heart failure: The heart failure patient's journey-the vulnerable phase: Bibliography of one hundred key papers 75
Arterial Stiffness And Ventricular-Arterial Coupling In Hfref. 75
De novo acute heart failure and acutely decompensated chronic heart failure: one single syndrome or two different entities? 74
Valore prognostico delle variazioni dell'indice di distribuzione dei volumi eritrocitari (RDW) nello scompenso cardiaco cronico. 73
Effect of bosentan on exercise capacity and clinical worsening in patients with dual Down and Eisenmenger syndrome 73
Acute heart failure 73
Carnosine: Potential aid for diabetes and cardiovascular disease 72
Body Mass Index Paradox In Acute Herat Failure 70
Reversal by the selective D2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensive patients. 67
Treatment of Patients Recently Admitted for Acute Heart Failure Based on NT-proBNP Plasma Levels Measurements. Results of a Prospective, Randomized, Single-centre Trial 67
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial) 67
School and family-based interventions for promoting a healthy lifestyle among children and adolescents in Italy: A systematic review 64
Highlights in heart failure 64
Prognostic value of blood urea nitrose and its changes in patients with chronic heart failure. 63
Le pressioni di riempimento ventricolari e la risposta ventilatoria allo sforzo identificano i pazienti con insufficienza cardiaca ad alto rischio di eventi nonostante la terapia beta-bloccante 62
December 2019 at a glance: economic burden, co-morbidities, and prognosis 61
Totale 10.319
Categoria #
all - tutte 86.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.487 0 153 144 411 220 448 350 429 274 579 209 270
2020/20213.291 124 450 98 444 191 382 98 368 358 367 262 149
2021/20221.621 72 245 42 119 48 77 42 142 80 197 166 391
2022/20231.749 262 92 27 125 168 468 5 165 274 14 84 65
2023/20242.064 124 32 210 172 123 422 92 77 410 50 47 305
2024/202589 46 43 0 0 0 0 0 0 0 0 0 0
Totale 16.281